These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
782 related items for PubMed ID: 18282435
1. [Managing children with neurofibromatosis type 1: what should we look for?]. Martins CL, Monteiro JP, Farias A, Fernandes R, Fonseca MJ. Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435 [Abstract] [Full Text] [Related]
2. Neurological complications involving the central nervous system in neurofibromatosis type 1. Hsieh HY, Wu T, Wang CJ, Chin SC, Chen YR. Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129 [Abstract] [Full Text] [Related]
3. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene]. Sabol Z, Kipke-Sabol L. Lijec Vjesn; 2005 Jun; 127(11-12):303-11. PubMed ID: 16583938 [Abstract] [Full Text] [Related]
10. Reproductive decisions after prenatal diagnosis in neurofibromatosis type 1: importance of genetic counseling. Terzi YK, Oguzkan-Balci S, Anlar B, Aysun S, Guran S, Ayter S. Genet Couns; 2009 Jun; 20(2):195-202. PubMed ID: 19650418 [Abstract] [Full Text] [Related]
11. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1. Nunley KS, Gao F, Albers AC, Bayliss SJ, Gutmann DH. Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418 [Abstract] [Full Text] [Related]
12. [From gene to disease; neurofibromatosis type 1]. de Goede-Bolder A, Cnossen MH, Dooijes D, van den Ouweland AM, Niermeijer MF. Ned Tijdschr Geneeskd; 2001 Sep 08; 145(36):1736-8. PubMed ID: 11572174 [Abstract] [Full Text] [Related]
13. [Neurofibromatosis type 1 in childhood]. Kongshaug N, Meyer B, Kolmannskog S. Tidsskr Nor Laegeforen; 1999 Aug 10; 119(18):2653-7. PubMed ID: 10479978 [Abstract] [Full Text] [Related]
14. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Hyman SL, Arthur Shores E, North KN. Dev Med Child Neurol; 2006 Dec 10; 48(12):973-7. PubMed ID: 17109785 [Abstract] [Full Text] [Related]
15. A clinical study of type 1 neurofibromatosis in north west England. McGaughran JM, Harris DI, Donnai D, Teare D, MacLeod R, Westerbeek R, Kingston H, Super M, Harris R, Evans DG. J Med Genet; 1999 Mar 10; 36(3):197-203. PubMed ID: 10204844 [Abstract] [Full Text] [Related]
17. Unusual clustering of brain tumours in a family with NF1 and variable expression of cutaneous features. Faravelli F, Upadhyaya M, Osborn M, Huson SM, Hayward R, Winter R. J Med Genet; 1999 Dec 10; 36(12):893-6. PubMed ID: 10593996 [Abstract] [Full Text] [Related]
18. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link? Van-Gils J, Harambat J, Jubert C, Vidaud D, Llanas B, Perel Y, Lacombe D, Goizet C. Eur J Med Genet; 2014 Dec 10; 57(11-12):639-42. PubMed ID: 25234363 [Abstract] [Full Text] [Related]
19. Diagnostic outcome in children with multiple café au lait spots. Korf BR. Pediatrics; 1992 Dec 10; 90(6):924-7. PubMed ID: 1344978 [Abstract] [Full Text] [Related]
20. Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1). Szudek J, Joe H, Friedman JM. Genet Epidemiol; 2002 Aug 10; 23(2):150-64. PubMed ID: 12214308 [Abstract] [Full Text] [Related] Page: [Next] [New Search]